CLEARBRIDGE, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 162 filers reported holding HAEMONETICS CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CLEARBRIDGE, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2015$4,791,000
+3.5%
148,600
+3.8%
0.09%
-2.1%
Q3 2015$4,629,000
-13.0%
143,210
+11.4%
0.09%
-1.1%
Q2 2015$5,318,000
-22.0%
128,570
-15.3%
0.10%
-20.2%
Q1 2015$6,818,000
+20.0%
151,7900.0%0.12%
+20.2%
Q4 2014$5,680,000
+7.1%
151,7900.0%0.10%0.0%
Q3 2014$5,301,000
-1.0%
151,7900.0%0.10%
-1.0%
Q2 2014$5,355,000
+8.2%
151,7900.0%0.10%
+6.4%
Q1 2014$4,947,000
-22.6%
151,7900.0%0.09%
-23.0%
Q4 2013$6,395,000
+5.7%
151,7900.0%0.12%
-1.6%
Q3 2013$6,053,000
-3.6%
151,7900.0%0.12%
+9.7%
Q2 2013$6,277,000151,7900.11%
Other shareholders
HAEMONETICS CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders